Voriconazole nanopolymeric (Samyang Biopharmaceuticals Corp)

伏立康唑纳米聚合物 (Samyang Biopharmaceuticals Corp)

Report date: 2025/08/28 20:00:09

Base Information

Drug NameVoriconazole nanopolymeric (Samyang Biopharmaceuticals Corp)
Drug Alias NameVoriconazole-loaded PNPVoriconazole-PNPSYP-1018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A